Richard Rawson, Ph.D.

ISAP Researchers' Profiles

Richard A. Rawson, Ph.D.

Richard A. Rawson, Ph.D., is an Associate Director of UCLA Integrated Substance Abuse Programs and Professor-in-Residence at the UCLA Department of Psychiatry, in which he has been a member for more than 20 years. He received a Ph.D. in experimental psychology from the University of Vermont in 1974. Dr. Rawson oversees clinical trials on pharmacological and psychosocial addiction treatments. He is principal investigator of the Los Angeles County Evaluation System Program (LACES) and the California Outcome System Monitoring Program (CalOMS). He has led addiction research and training projects for the United Nations, the World Health Organization, and the U.S. State Department, exporting science-based knowledge to many parts of the world. Dr. Rawson has published 3 books, 33 book chapters, and over 200 peer-reviewed articles and has conducted over 1,000 workshops, paper presentations, and training sessions.

Education and Training

  • University of Vermont, Burlington, VT, B.A., Psychology, 1970
  • University of Vermont, Burlington, VT, Ph.D., Psychology, 1974

Specialties

  • Methamphetamine
  • Behavioral Treatment Research
  • Medication Research
  • Treatment System Evaluation
  • International Addiction Research
  • Addiction Training

Contact Info

UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
rrawson@mednet.ucla.edu

Selected Publications

Selected Peer-reviewed Publications (From a List of 175+)

  1. Anderson, A.L., Li, S.-H., Biswas, K., McSherry, F., Holmes, T., Iturriaga, E., Kahn, R., Chiang, N., Beresford, T., Campbell, J., Haning, W., Mawhinney, J., McCann, M., Rawson, R., Stock, C., Weis, D., Yu, E., Elkashef, A.M. (in press). Modafinil for the treatment of methamphetamine dependence. Drug and Alcohol Dependence. Aug 11. [Epub ahead of print]
  2. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2011). Bulimia nervosa among methamphetamine dependent adults: Association with outcomes three years after treatment. Eating Disorders: The Journal of Treatment and Prevention, 19(3), 259-269.  PMID: 21516550
  3. Baser, O., Chalk, M., Rawson, R., & Gastfriend, D.R. (2011). Alcohol dependence treatments: Comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. The American Journal of Managed Care, 17(8), S222-S234.
  4. Dickerson, D., Spear, S., Marinelli-Casey, P., Rawson, R.A., Li, L., & Hser, Y.-I. (2011). American Indians/Alaska Natives and substance abuse treatment outcomes: Positive signs and continuing challenges. Journal of Addictive Diseases, 30(1), 63-74.
  5. Gonzales, R., Brecht, M.-L., Mooney, L., & Rawson, R.A. (2011). Prescription and over-the-counter drug treatment admissions to the California public treatment system. Journal of Substance Abuse Treatment, 40(3), 224-229.
  6. Gonzales, R., Ang, A., Glik, D.C., Rawson, R.A., Lee, S., Iguchi, M.Y.; Methamphetamine Treatment Project Corporate Authors. (2011). Quality of life among treatment seeking methamphetamine-dependent individuals. The American Journal on Addictions, 20(4), 366-372.  PMID: 21679268
  7. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.; Methamphetamine Treatment Project Corporate Authors. (2010). Anxiety disorders among methamphetamine dependent adults: Association with post-treatment functioning. American Journal on Addictions, 19(5), 385-390. PMID: 20716300
  8. Momtazi, S., & Rawson, R. (2010). Substance abuse among Iranian high school students. Current Opinion in Psychiatry, 23, 221-226.  
  9. Zorick, T., Nestor, L., Miotto, K., Sugar, C., Hellemann, G., Scanlon, G., Rawson, R., & London, E.D. (2010). Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction,  105(10), 1809-1818.  PMID: 20840201
  10. Crèvecoeur-MacPhail, D., Bellows, A., Rutkowski, B.A., Ransom, L., Myers, A.C., & Rawson, R.A. (2010).  “I’ve been NIATxed”: Participants’ experience with process improvement.  Journal of Psychoactive Drugs, SARC Supplement 6, 249-259.
  11. Crèvecoeur-MacPhail, D., Ransom,  L., Myers, A.C., Annon, J.J., Diep, N., Gonzales, R., Rawson, R.A.,  Viernes, J., Jr.,  Sugita, W., & Barger, J. (2010). Inside the black box: Measuring addiction treatment services and their relation to outcomes. Journal of Psychoactive Drugs, SARC Supplement 6, 269-276.
  12. Davoudi, M., & Rawson, R.A. (2010). Screening, brief intervention, and referral to treatment (SBIRT) initiatives in California: Notable trends, challenges, and recommendations. Journal of Psychoactive Drugs, SARC Supplement 6, 239-248.
  13. Herbeck, D.M., Gonzales, R., & Rawson, R.A. (2010). Performance improvement in addiction treatment: Efforts in California. Journal of Psychoactive Drugs, SARC Supplement 6, 261-268.
  14. Rawson, R.A., Gonzales, R., Crèvecoeur-MacPhail, D., Urada, D., Brecht, M.-L., Chalk, M., Kemp, J., & Cunningham, M. (2010). Improving the accountability of California’s public substance abuse treatment system through the implementation of performance models. Journal of Psychoactive Drugs, SARC Supplement 6, 211-214.
  15. Rutkowski, B.A., Rawson, R.A.,  & Freese, T.E.(2010). Editors’ introduction: Improving the addiction treatment system in California through the use of data and evidence-based practices – California Substance Abuse Research Consortium (SARC) meetings, 2009. Journal of Psychoactive Drugs, SARC Supplement 6, 207-210.
  16. Tomás-Rosselló, J., Rawson, R.A., Zarza, M.J., Bellows, A., Busse, A., Saenz, E., Freese, T., Shawkey, M., Carise, D., Ali, R., & Ling, W. (2010). United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resources Centres: Treatnet. Substance Abuse, 31, 251-263.

Last updated - 01/31/2012

Click here to view other profiles.

Top of Page